elbows
Well-Known Member
The usual story then, same sort of stuff as Whitty mentioned recently, ie the last sentence from this bit of the abstract of that study:
I think its been pretty clear from the start of Omicron that it does not lead us 'all the way back to square one' in this pandemic. But beyond that, I mostly have to wait for the full UK picture of how much its eroded our protection to emerge. The number of infections we allow in this country will certainly provide huge amounts of data in time.
Early analyses suggest a reduced risk of hospitalisation among SGTF-infected individuals when compared to non-SGTF infected individuals in the same time period, and a reduced risk of severe disease when compared to earlier Delta-infected individuals. Some of this reduction is likely a result of high population immunity.
I think its been pretty clear from the start of Omicron that it does not lead us 'all the way back to square one' in this pandemic. But beyond that, I mostly have to wait for the full UK picture of how much its eroded our protection to emerge. The number of infections we allow in this country will certainly provide huge amounts of data in time.
Last edited: